New York, NY – January 15, 2014 – Ai Cure Technologies, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, announced today a change of its name to AiCure. The new name emphasizes the company’s commitment to improving human health through intelligent solutions. The change is effective immediately.
“This elegant simplification aligns well with our mission to improve human health. Wherever medication adherence is critical, AiCure offers unparalleled accuracy and insight into patient behavior. It is the intelligence and power behind our platform which enables deployment and usage to be so easy and efficient.” said Adam Hanina, CEO.
The company’s new name reflects its commitment to reducing risk in clinical research, providing efficiencies in population health management, and aligning branded pharmaceuticals with the health outcomes of the patient populations they serve.